A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer
Open Access
- 22 January 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (2) , 305-310
- https://doi.org/10.1038/sj.bjc.6604862
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast CancerJournal of Clinical Oncology, 2006
- Benefit of taxanes as adjuvant chemotherapy for early breast cancerCancer, 2006
- Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized TrialJournal of Clinical Oncology, 2001
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 2000
- Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.1995
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.Journal of Clinical Oncology, 1990
- Reporting results of cancer treatmentCancer, 1981